Blokium Flexi tablets are used to relieve muscle and joint pain and reduce inflammation. Pack of 15 tablets.
Composition:
Each coated tablet contains:
• Diclofenac sodium – 50.00 mg;
• Pridinol mesylate – 4.00 mg.
Excipients:
• Lactose monohydrate – 95.00 mg;
• Microcrystalline cellulose – 34.00 mg;
• Sodium croscarmellose – 9.00 mg;
• Magnesium stearate – 1.80 mg;
• Colloidal silicon dioxide – 2.00 mg;
• Hydroxypropyl methylcellulose E15 – 7.33 mg;
• Yellow iron oxide – 95.20 mcg;
• Red iron oxide – 18.10 mcg;
• Titanium dioxide – 0.57 mg;
• Polyethylene glycol 6000 – 1.33 mg;
• Talc – 4.77 mg.
Physicochemical properties:
Round, semi-elliptical coated tablets with a thin yellowish-brown film coating.
Average weight: 210 mg ± 5%.
Dissolution: Q=70% (diclofenac sodium).
Tightness: not less than 99.5%.
ATC code: M03BX03
Therapeutic properties:
Analgesic, anti-inflammatory, and muscle relaxant.
Indications:
Blocium Flex is used for:
• Painful inflammatory muscle contractures;
• Joint and extra-articular rheumatic conditions;
• Myalgia;
• Lower back pain;
• Sciatica;
• Torticollis;
• Injuries;
• Tendon strains.
Pharmacological action:
Diclofenac is a non-steroidal anti-inflammatory drug that mainly acts by inhibiting prostaglandin synthesis.
Pridinol is a centrally acting muscle relaxant that effectively reduces muscle spasms.
Dosage and method of administration:
One tablet once daily after meals. The dose may be adjusted according to the doctor’s recommendation.
Contraindications:
Do not use in cases of:
• Allergy to any component of the medicine;
• Active gastrointestinal ulcers;
• Severe liver and/or kidney failure;
• History of asthma, rhinitis, or urticaria associated with acetylsalicylic acid or other non-steroidal anti-inflammatory drugs;
• Pregnancy and breastfeeding.
Overdose:
Symptoms of acute overdose may include:
• Headache;
• Psychomotor agitation;
• Muscle spasms;
• Convulsions;
• Epigastric pain;
• Nausea;
• Vomiting;
• Hematemesis;
• Diarrhea;
• Gastrointestinal ulcers;
• Impaired liver function;
• Oliguria.
If necessary, contact a toxicology center.
Initial treatment of overdose:
In case of overdose, gastric lavage or induced vomiting is recommended.
Since the medicine is excreted through urine, forced diuresis may be considered. The effectiveness of dialysis or hemoperfusion in eliminating the drug has not been established. Activated charcoal may reduce drug absorption.
Packaging:
15 and 30 coated tablets in a container.
Shelf life:
24 months.
Storage conditions:
Store in a cool, dry place at a temperature of 15-30°C, out of reach of children.